These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8720064

  • 21. Expression of the feline herpesvirus type 1 ICP4 gene is controlled by two alternative promoters.
    Kawaguchi Y, Maeda K, Yokoyama N, Fujita K, Ono M, Tohya Y, Mikami T.
    Arch Virol; 1997; 142(2):239-53. PubMed ID: 9125041
    [Abstract] [Full Text] [Related]

  • 22. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
    Waters AK, De Parseval AP, Lerner DL, Neil JC, Thompson FJ, Elder JH.
    Virology; 1996 Jan 01; 215(1):10-6. PubMed ID: 8553580
    [Abstract] [Full Text] [Related]

  • 23. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
    Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B.
    J Neurovirol; 2001 Jun 01; 7(3):235-49. PubMed ID: 11517398
    [Abstract] [Full Text] [Related]

  • 24. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.
    Plumb M, Fulton R, Breimer L, Stewart M, Willison K, Neil JC.
    J Virol; 1991 Apr 01; 65(4):1991-9. PubMed ID: 1848314
    [Abstract] [Full Text] [Related]

  • 25. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
    Ryden TA, de Mars M, Beemon K.
    J Virol; 1993 May 01; 67(5):2862-70. PubMed ID: 8386280
    [Abstract] [Full Text] [Related]

  • 26. Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells.
    Miyazawa T, Inoshima Y, Kohmoto M, Ikeda Y, Mikami T.
    J Vet Med Sci; 1994 Oct 01; 56(5):869-72. PubMed ID: 7532437
    [Abstract] [Full Text] [Related]

  • 27. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD, Huong SM, Huang ES.
    J Hum Virol; 1999 Oct 01; 2(2):81-90. PubMed ID: 10225210
    [Abstract] [Full Text] [Related]

  • 28. Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat.
    Ikeda Y, Inoshima Y, Kawaguchi Y, Maeda K, Kohmoto M, Kai C, Miyazawa T, Mikami T.
    J Gen Virol; 1998 Jan 01; 79 ( Pt 1)():95-9. PubMed ID: 9460929
    [Abstract] [Full Text] [Related]

  • 29. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat.
    Nonnemacher MR, Hogan TH, Quiterio S, Wigdahl B, Henderson A, Krebs FC.
    Biomed Pharmacother; 2003 Jan 01; 57(1):34-40. PubMed ID: 12642035
    [Abstract] [Full Text] [Related]

  • 30. Relative activity of the feline immunodeficiency virus promoter in feline and primate cell lines.
    Mustafa F, Jayanth P, Phillip PS, Ghazawi A, Schmidt RD, Lew KA, Rizvi TA.
    Microbes Infect; 2005 Feb 01; 7(2):233-9. PubMed ID: 15725384
    [Abstract] [Full Text] [Related]

  • 31. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone.
    Miyazawa T, Kawaguchi Y, Kohmoto M, Sakuragi J, Adachi A, Fukasawa M, Mikami T.
    J Gen Virol; 1992 Jun 01; 73 ( Pt 6)():1543-6. PubMed ID: 1318947
    [Abstract] [Full Text] [Related]

  • 32. Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus.
    Sato E, Yokoyama N, Maeda K, Inoshima Y, Kohmoto M, Ikeda Y, Miyazawa T, Mikami T.
    Arch Virol; 1998 Jun 01; 143(3):453-66. PubMed ID: 9572547
    [Abstract] [Full Text] [Related]

  • 33. Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein.
    Ryden TA, Beemon K.
    Mol Cell Biol; 1989 Mar 01; 9(3):1155-64. PubMed ID: 2725492
    [Abstract] [Full Text] [Related]

  • 34. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
    Pancino G, Castelot S, Sonigo P.
    Virology; 1995 Feb 01; 206(2):796-806. PubMed ID: 7856093
    [Abstract] [Full Text] [Related]

  • 35. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.
    Miyazawa T, Fukasawa M, Hasegawa A, Maki N, Ikuta K, Takahashi E, Hayami M, Mikami T.
    J Virol; 1991 Mar 01; 65(3):1572-7. PubMed ID: 1847473
    [Abstract] [Full Text] [Related]

  • 36. Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
    Gu Q, Zhang Z, Cano Ortiz L, Franco AC, Häussinger D, Münk C.
    J Virol; 2016 Dec 01; 90(23):10545-10557. PubMed ID: 27630243
    [Abstract] [Full Text] [Related]

  • 37. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.
    Honda Y, Rogers L, Nakata K, Zhao BY, Pine R, Nakai Y, Kurosu K, Rom WN, Weiden M.
    J Exp Med; 1998 Oct 05; 188(7):1255-65. PubMed ID: 9763605
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
    Banders UT, Coussens PM.
    Virology; 1994 Feb 15; 199(1):1-10. PubMed ID: 8116231
    [Abstract] [Full Text] [Related]

  • 40. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
    Dahiya S, Liu Y, Nonnemacher MR, Dampier W, Wigdahl B.
    PLoS One; 2014 Feb 15; 9(2):e88116. PubMed ID: 24551078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.